c/o Eli Lilly and Company,c/o Eli Lillyand Company
申请号：
MEP20174
公开号：
ME02576B
申请日:
2017.02.10
申请国别(地区):
ME
年份:
2017
代理人:
摘要：
The present invention provides compounds of Formula I useful as BACE inhibitors in the treatment of e.g. Alzheimer's disease: wherein A is selected from the group consisting of； of； R1 is H or F； R2 is H, &mdash；OCH3, C1-C3 alkyl； R3 is H, &mdash；CH3, or &mdash；OCH3； and R4 is H or F； or a pharmaceutically acceptable salt thereof.
